Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Frontiers in Psychiatry
|
March 21, 2019
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung-Wan Kim, Hee-Ju Kang, Min Jhon, et al.
The Australian and New Zealand Journal of Psychiatry
|
June 7, 2024
Development of a harmonized sociodemographic and clinical questionnaire for mental health research: A Delphi-method-based consensus recommendation
Mojtaba Lotfaliany, Bruno Agustini, Adam J Walker, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for Schizophrenia
Alyna Turner, John J McGrath, Olivia M Dean, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo
Alyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open
|
March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
Chiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Psychiatric Research
|
August 26, 2021
Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
Chiara C Bortolasci, Alyna Turner, Mohammadreza Mohebbi, et al.
Brain, Behavior, & Immunity - Health
|
January 12, 2023
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
Adam J Walker, Mohammadreza Mohebbi, Michael Maes, et al.
Biological Psychiatry
|
December 20, 2021
The Australian Genetics of Depression Study: New Risk Loci and Dissecting Heterogeneity Between Subtypes
Brittany L Mitchell, Adrian I Campos, David C Whiteman, et al.
Bipolar Disorders
|
April 23, 2025
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis
Matthew J Y Kang, Dhamidhu Eratne, Olivia Dean, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Frontiers in Psychiatry
|
March 21, 2019
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung-Wan Kim, Hee-Ju Kang, Min Jhon, et al.
The Australian and New Zealand Journal of Psychiatry
|
June 7, 2024
Development of a harmonized sociodemographic and clinical questionnaire for mental health research: A Delphi-method-based consensus recommendation
Mojtaba Lotfaliany, Bruno Agustini, Adam J Walker, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for Schizophrenia
Alyna Turner, John J McGrath, Olivia M Dean, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 3, 2022
The role of metformin as a treatment for neuropsychiatric illness
Seetal Dodd, Luba Sominsky, Dan Siskind, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo
Alyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open
|
March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis
Chiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Psychiatric Research
|
August 26, 2021
Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
Chiara C Bortolasci, Alyna Turner, Mohammadreza Mohebbi, et al.
Brain, Behavior, & Immunity - Health
|
January 12, 2023
Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
Adam J Walker, Mohammadreza Mohebbi, Michael Maes, et al.
Biological Psychiatry
|
December 20, 2021
The Australian Genetics of Depression Study: New Risk Loci and Dissecting Heterogeneity Between Subtypes
Brittany L Mitchell, Adrian I Campos, David C Whiteman, et al.
Bipolar Disorders
|
April 23, 2025
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis
Matthew J Y Kang, Dhamidhu Eratne, Olivia Dean, et al.
Page
of 6